- Home
- AMBC vs MREO Comparison
AMBC vs MREO Comparison
Compare AMBC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- MREO
- Stock Information
- Founded
- AMBC 1971
- MREO 2015
- Country
- AMBC United States
- MREO United Kingdom
- Employees
- AMBC N/A
- MREO N/A
- Industry
- AMBC Property-Casualty Insurers
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- MREO Health Care
- Exchange
- AMBC Nasdaq
- MREO Nasdaq
- Market Cap
- AMBC 411.3M
- MREO 424.5M
- IPO Year
- AMBC 1991
- MREO N/A
- Fundamental
- Price
- AMBC $6.76
- MREO $2.85
- Analyst Decision
- AMBC Strong Buy
- MREO Strong Buy
- Analyst Count
- AMBC 1
- MREO 7
- Target Price
- AMBC $15.00
- MREO $7.71
- AVG Volume (30 Days)
- AMBC 1.1M
- MREO 1.2M
- Earning Date
- AMBC 08-04-2025
- MREO 08-12-2025
- Dividend Yield
- AMBC N/A
- MREO N/A
- EPS Growth
- AMBC N/A
- MREO N/A
- EPS
- AMBC N/A
- MREO N/A
- Revenue
- AMBC $253,912,000.00
- MREO N/A
- Revenue This Year
- AMBC N/A
- MREO N/A
- Revenue Next Year
- AMBC $17.41
- MREO $54.07
- P/E Ratio
- AMBC N/A
- MREO N/A
- Revenue Growth
- AMBC 125.08
- MREO N/A
- 52 Week Low
- AMBC $5.99
- MREO $1.58
- 52 Week High
- AMBC $13.64
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- AMBC 38.39
- MREO 64.74
- Support Level
- AMBC $6.65
- MREO $2.61
- Resistance Level
- AMBC $7.18
- MREO $2.85
- Average True Range (ATR)
- AMBC 0.35
- MREO 0.17
- MACD
- AMBC -0.05
- MREO 0.03
- Stochastic Oscillator
- AMBC 17.88
- MREO 88.83
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).